William M. Greenman - May 26, 2023 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Stock symbol
KDNY
Transactions as of
May 26, 2023
Transactions value $
-$26,912
Form type
4
Date filed
5/31/2023, 07:26 PM
Previous filing
Mar 14, 2023
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDNY Common Stock Options Exercise +3.3K +15.35% 24.8K May 26, 2023 Direct F1
transaction KDNY Common Stock Sale -$26.9K -1.16K -4.66% $23.30 23.6K May 30, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Restricted Stock Units Options Exercise $0 -3.3K -100% $0.00* 0 May 26, 2023 Common Stock 3.3K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-l trading plan previously adopted by the Reporting Person and represent shares by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.
F3 Each RSU represents a contingent right to receive one share of Issuer's common stock.
F4 100% of the RSUs vested on May 26, 2023, subject to the Reporting Persons continued service to the Issuer on the vesting date.